Real-world data backs anti-IL-5 use in COPD with comorbid asthma
GlobalData’s latest analysis highlights the results of a retrospective study from Ghent University Hospital based on Belgian…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
benralizumab
AstraZeneca’s Asthma drug Benralizumab gets marketing approval from DCGI
Benralizumab is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients
AstraZeneca Pharma India gets DCGI nod for benralizumab injection, Fasenra
It is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients
FASENRA eliminated OCS in a majority of asthma patients in PONENTE Phase IIIb trial
62 per cent of patients stopped OCS use completely